Physician profile
Michael A Chiusano
NPI 1366415150
$1,384.87
in general payments reported to CMS, 2019-2025
13 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $420 · 2020: $181 · 2021: $285 · 2022: $54.49 · 2023: $21.62 · 2024: $423.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $445.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $444.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Procept Biorobotics Corporation | $394.21 | 2024 | Aquabeam System |
| Astellas Pharma US INC | $289.73 | 2019-2021 | |
| Pfizer INC. | $180.14 | 2019-2021 | |
| Dendreon Pharmaceuticals LLC | $170.65 | 2020-2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $86.96 | 2019-2024 | |
| Janssen Biotech, INC. | $58.89 | 2020-2021 | |
| 180 Medical, INC. | $40.72 | 2019-2020 | |
| Tolmar Pharmaceuticals, INC. | $38.50 | 2022 | |
| Neotract INC. | $37.08 | 2019 | |
| Merck Sharp & Dohme LLC | $29.72 | 2020-2022 | |
| Amgen INC. | $23.75 | 2019 | |
| Antares Pharma, INC. | $22.02 | 2019 | |
| Myovant Sciences INC. | $12.50 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Chiusano listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.